The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 28, 2016

Filed:

Oct. 11, 2013
Applicants:

Abbvie Deutschland Gmbh & Co. KG, Wiesbaden, DE;

Abbvie Inc., North Chicago, IL (US);

Inventors:

Andreas Haupt, Wiesbaden, DE;

Jürgen Dinges, North Chicago, IL (US);

Liliane Unger, Ludwigshafen, DE;

Karsten Wicke, Ludwigshafen, DE;

Robert van Waterschoot, Riehen, CH;

Scott Mittelstadt, North Chicago, IL (US);

Karla Drescher, Ludwigshafen, DE;

Ana Relo, Ludwigshafen, DE;

Assignees:

ABBVIE DEUTSCHLAND GMBH & CO. KG, Wiesbaden, DE;

ABBVIE INC., North Chicago, IL (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/496 (2006.01); C07D 239/42 (2006.01); C07D 403/04 (2006.01); C07D 405/14 (2006.01); C07D 239/26 (2006.01); C07D 405/04 (2006.01);
U.S. Cl.
CPC ...
C07D 239/26 (2013.01); C07D 239/42 (2013.01); C07D 403/04 (2013.01); C07D 405/04 (2013.01); C07D 405/14 (2013.01);
Abstract

The present invention relates to novel acylaminocycloalkyl compounds, in particular to the compounds of the formula I as described herein and to their salts and N-oxides. The compounds possess valuable therapeutic properties and are suitable, in particular, for treating diseases that respond to modulation of the dopamine D3 receptor.


Find Patent Forward Citations

Loading…